StockVS

TSX · CAD · ETF

Middlefield Healthcare Dividend ETF (MHCD.TO) ETF Analysis

MHCD.TO
Yield 2.96% Assets CA$155.27M Since July 21, 2017 Family Middlefield Limited
CA$12.53
−CA$0.09 (−0.67%)

September 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MHCD.TO with… →

Top Holdings

# Symbol Name Weight
1 LLY Eli Lilly and Co 7.37%
2 JNJ Johnson & Johnson 6.49%
3 ABBV AbbVie Inc 5.21%
4 MRK Merck & Co Inc 4.71%
5 TMO Thermo Fisher Scientific Inc 4.31%
6 AZN.L AstraZeneca PLC 3.61%
7 SYK Stryker Corp 3.09%
8 DHR Danaher Corp 2.78%
9 ABT Abbott Laboratories 2.77%
10 NOVN.SW Novartis AG Registered Shares 2.69%

Analysis

Data-derived

Fund Overview

Middlefield Healthcare Dividend ETF (MHCD.TO) is an exchange-traded fund. Total net assets stand at CA$155.27M. The fund is issued by Middlefield Limited. It has been trading since July 21, 2017.

The largest positions on file are Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV). Eli Lilly and Co alone accounts for 7.37% of the portfolio. The ten largest positions together make up 43.02% of the fund.

Performance Analysis

MHCD.TO last closed at CA$12.53 on September 4, 2026. Over the trailing twelve months the price has returned +20.12%. Across 5 years the annualized return works out at +6.28%. The trailing distribution yield is 2.96%.

So far in 2026 the price is +9.22%. Across the complete calendar years on file, 2021 returned +16.25% and 2022 returned −2.50%. Of the 7 complete calendar years on file, 6 finished higher.

Price & Risk Profile

Daily returns over the trailing 8 years annualize to a volatility of 16.32%. The reported beta is 1.01. Over the past 52 weeks the price has ranged from CA$10.69 to CA$12.91. The latest close sits 17.21% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Similar ETFs